My watch list  

GATC Biotech AG

Wherever there is DNA - there is GATC

As a pioneer in the sequencing field, GATC Biotech is Europe’s leading service provider of sequencing and bioinformatics. For over 27 years the company has developed innovative sample-to-answer solutions for DNA and RNA sequencing with bioinformatics analysis for industry, research, and health care.

The highly integrated and fully automated processes for Sanger as well as for next-generation sequencing and diagnostic solutions deliver reliable, ready-to-use results backed by ISO 17025 accreditation and ISO 13485 certification. Currently, one of the company’s entrepreneurial focuses is on a completely new approach in the field of personalised medicine. GATCLIQUID is the world’s first service for cancer research and diagnosis based on liquid biopsy.

GATC Biotech offers unmatched flexibility to customers interested in any kind of genomics, such as transcriptome, epigenome, exome or whole genome analysis. The company is involved in numerous successful collaborations with world-renowned universities, academic institutions, pharmaceutical and biotechnological companies. Moreover, GATC Biotech has a proven record of publicly funded projects by the EU and other national agencies.

More about GATC Biotech
  • News

    GATC to be part of Eurofins Group

    GATC will be a part of the Eurofins Group as of July 2017 to create the leading company in the worldwide sequencing market. Eurofins Scientific announces that it has signed an agreement to acquire GATC Biotech AG, one of Europe´s specialists in DNA sequencing. The transaction is expected to ... more

    MolecularHealth Partners with GATC Biotech for Genetic Sequencing Technology and Expertise

    MolecularHealth announced a unique agreement with GATC Biotech. GATC Biotech will provide protocols, support and extensive training of MolecularHealth’s laboratory staff. Additionally, MolecularHealth will use GATC Biotech’s LIMS (Laboratory Information Management System) in itsnewly opened ... more

    GATC Biotech conducts research to detect cancer in women

    GATC Biotech has started research on early detection of breast and ovarian cancer with the goal of developing a test to identify tumor markers present in blood and link these markers to the presence of cancer. As a partner of the research project EpiFemCare, GATC Biotech will manage sample ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE